Severe Refractory Eosinophilic Asthma
This section highlights clinical protocols for a range of drugs.
Benralizumab for Severe Refractory Eosinophilic Asthma, Version 6 (PDF, size 844 KB, 5 pages)
Mepolizumab for Severe Refractory Eosinophilic Asthma, Version 7 (PDF, size 840 KB, 5 pages)
Reslizumab for Severe Refractory Eosinophilic Asthma, Version 4 ( PDF, size 479 KB, 5 pages)